The Saga of Freeze-Drying

Rey,Louis;

The Saga of Freeze-Drying

March 1, 2004

By Louis Rey, PhD

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-03-01-2004

Volume 2004 Supplement

Issue 2

Though recognized by the public since freeze-dried coffee hit the market 30 years ago, lyophilization remains far from mature and deserves more research.

External Link - article-84716.pdf

Articles in this issue

Understanding Lyophilization Formulation Development

Low-Temperature Thermal Analysis are Key to Formulation Design

The Saga of Freeze-Drying

Related Content

Sterile capsules for injection. Bottles on the bottling line of the pharmaceutical plant. Machine after checking sterile liquids. Interferon, nasoferon. | Image Credit: © neznamov1984 - stock.adobe.com

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

Patrick Lavery

July 1st 2025

Article

The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney

June 27th 2025

Article

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.